skip to content

Sickle Cell Treatment Approved for Phase III Clinical Trial

April 24, 2009

Emmaus Medical, Inc., a Torrance, California based pharmaceutical company, announced this week that the Food and Drug Administration gave its approval for Emmaus Medical to begin a Phase 3 clinical trial of an experimental treatment for sickle cell disease.